Multiple sclerosis treatment approach developed at Mainz University moves toward clinical application
A therapeutic approach pioneered in Mainz for the treatment of multiple sclerosis (MS) is taking an important step…
Brain organoid studies on the ISS move closer to new treatments
Research using human brain organoids onboard the International Space Station International Space Station (ISS) helped lead to the…
Novel salvage surgical approach for refractory multiple sclerosis-related trigeminal neuralgia
A case report in Chinese Neurosurgical Journal describes a novel salvage surgical approach for refractory multiple sclerosis-related trigeminal…
Low-cost B-cell depleting therapy is as effective as standard treatment for multiple sclerosis
A Norwegian Swedish clinical trial published in the New England Journal of Medicine (NEJM) demonstrates that rituximab, a…
EULAR 2026 highlights rising comorbidity risks in rheumatic disease
People with rheumatic and musculoskeletal diseases (RMD) are at risk of a number of comorbidities, from cardiovascular diseases…
Ocrelizumab slows disability progression in advanced progressive multiple sclerosis
A major international phase III clinical trial, led by Queen Mary University of London, has found that ocrelizumab…
Preclinical models map genetic changes behind multiple sclerosis nerve damage
More than 1 million people across the United States live with multiple sclerosis (MS), a disease that affects…
Qureight to support Mediar Therapeutics’ Phase 2 trial of MTX-474 in diffuse cutaneous Systemic Sclerosis
Qureight, an end-to-end imaging CRO that provides enterprise-grade imaging and precision endpoints for clinical trials with a focus…
Concerns rise over breast cancer risk and gender-based efficacy of Ocrevus
The US Food and Drug Administration (FDA) is reviewing a petition to revoke the approval of Roche’s top-selling…
Gut immune responses found to trigger brain inflammation in MS
Multiple sclerosis (MS) is a debilitating neurological disorder caused by malfunctioning immune responses that target the brain and…
Swedish study reveals COVID-19 may increase glandular fever risk
Even individuals who did not become seriously ill with COVID-19 may have developed a weakened immune system that…
New study identifies specific brain cells most vulnerable to ALS and dementia
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) belong to a spectrum of neurodegenerative diseases with overlapping symptoms,…